Windsor, CA, United States of America

Bulent Mutus

This inventor holds 1 USPTO granted patent. Top assignee: University of Windsor. Active years: 2016.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Bulent Mutus

Introduction

Bulent Mutus is a notable inventor based in Windsor, California. He has made significant contributions to the field of medical technology, particularly in the area of wound healing. His work focuses on the therapeutic applications of nitric oxide, which has been recognized for its potential benefits in treating cutaneous injuries.

Latest Patents

Bulent Mutus holds a patent for an "Apparatus for the controlled release of topical nitric oxide." This invention features a stable delivery system designed for the therapeutic release and application of nitric oxide to patients suffering from skin injuries or wounds. The system includes S-nitrosothiol and transition element nanoparticles. These nanoparticles are specifically selected to react with the S-nitrosothiol, facilitating the release and diffusion of nitric oxide into the injury or wound.

Career Highlights

Bulent Mutus is affiliated with the University of Windsor, where he continues to advance his research and innovation in medical applications. His work has garnered attention for its potential to improve patient outcomes in wound care.

Collaborations

Bulent has collaborated with notable colleagues, including Arthur Jarosz and Adam Faccenda. Their combined expertise contributes to the ongoing development of innovative solutions in the medical field.

Conclusion

Bulent Mutus exemplifies the spirit of innovation in medical technology through his patent and research efforts. His work on nitric oxide delivery systems holds promise for enhancing wound healing and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…